Magnostics is developing a rapid screening test for Acute Mesenteric Ischemia, which has mortality rate of 60-80%
A provisional patent application has been submitted with the USPTO and a PCT application will be submitted latter this year.
Under evaluation at least till: 26th of March 2o23
Better Care Better Care provides medical device integration...
Goliver Therapeutics Goliver Therapeutics treats severe acu...
LabSafe Metrics LabSafe Metrics uses AI to predict drug rel...